Latest filing published 20 Apr 2017 for Invivo Therapeutics Holdings CORP., €8,475.
Insider track record
Richard John Roberts: trading record in brief
Richard John Roberts discloses dealings in Invivo Therapeutics Holdings Corp. to SEC (Form 4). Between 8 August 2014 and 13 April 2017, the trades on record add up to 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 20 April 2017 with an option exercise (€8,475) in Invivo Therapeutics Holdings Corp. The median gap between a trade and its publication by SEC (Form 4) is 6 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard John Roberts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,984 shares@ US$0.290415.0% of flowCommon StockSEC:0001179110-17-006131:0
- 58,403 shares@ US$0.290428.2% of flowCommon StockSEC:0001179110-17-002644:0
- 70,000 shares@ US$0.290431.6% of flowCommon StockSEC:0001104659-16-141056:0
- 20,000 shares@ US$0.29049.3% of flowCommon StockSEC:0001179110-16-021307:0
- 35,000 shares@ US$0.290415.9% of flowCommon StockSEC:0001179110-16-021307:1
- 10,000 shares@ US$0.0726Common StockSEC:0001179110-14-012768:0
6 of 6 declarations